Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 33 - Medicinal preparations containing inorganic active ingredients
Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
07/2003
07/10/2003US20030130201 Mixture with ascorbic acid, proline and lysine
07/10/2003US20030129256 Half-hydrate gypsum and an aqueous solution containing water, a polyol, and a solidification promoter selected from a polysaccharide, a polyethylene alcohol or mixtures thereof; prolonged working time and shortened setting time
07/10/2003US20030129255 Colloidal silver is added periodically to the aquarium so that the water has a silver concentration on the order of 1 ppb
07/10/2003US20030129228 Magnesium plus interactive agent delivery
07/10/2003US20030129183 Hemostatic compositions, devices and methods
07/10/2003CA2464937A1 Long chain fatty alcohol substituents in antineoplastic agents
07/09/2003EP1324782A2 Stabilized hydrogen peroxide solutions
07/09/2003EP1324758A1 Method for preparing microspheres containing a water-soluble substance
07/09/2003EP1324753A2 Compositions and methods for lowering plasma lipoprotein(a) and risk factors of cardiovascular diseases
07/09/2003EP1272232A4 Calcium phosphate artificial bone as osteoconductive and biodegradable bone substitute material
07/09/2003CN1429276A Modulating production of pneumococcal capsular polysaccharide
07/09/2003CN1429119A Method for preparation of polymeric micelle via separation of block copolymer
07/09/2003CN1429114A 联合化学疗法 Combined chemotherapy
07/09/2003CN1429113A Nutritional preparation comprising ribose and folic acid and medical use thereof
07/09/2003CN1113661C Chinese medicine for eliminating thick sputum and clearing away heat and toxic material and its preparing method
07/09/2003CN1113659C Chinese patent medicine for treating gastritis
07/08/2003US6589987 Dithiocarbamate, particularly tetraethylthiuram disulfide strongly inhibits the growth of cancer cells of a variety of cell types. Such inhibitory effect is enhanced by heavy metal ions such as copper ions, cytokines and ceruloplasmin and
07/08/2003US6589941 Preventing or reducing formation of resistance in cytostatic treatment comprising combining BVDU, a salt thereof or BVDU in protected form or in prodrug form with at least one cytostatic agent in order to prevent or reduce the formation
07/08/2003US6589576 Includes xanthan gum which improves tolerance (e.g. less gastrointestinal symptoms such as emesis, stool patterns and gas)
07/08/2003US6589568 Therapeutic body lotion containing alkali metal hypohalite
07/08/2003US6589567 Anti-cancer therapy agent of arsenic hexoxide (As4O6) of a natural chemical substance and its pharmaceutical composition
07/08/2003US6589566 Composition comprising theanine
07/08/2003US6589564 Magnesium lactate, magnesium asparate, magnesium acetate, magnesium pyrophosphate
07/08/2003US6589535 Nutritional supplement based on blackcurrent seed oil
07/08/2003US6589507 Fast acting; chewable; acid binder, carbon dioxide efferves-cent compound, nonionic surfactant and swellable, gel forming polymer
07/08/2003US6589223 Method and compositions for use in perfusion applications
07/08/2003CA2321232C Oral care compositions comprising chlorite and methods
07/03/2003WO2003053997A2 Methods of increasing endogenous erythropoietin (epo)
07/03/2003WO2003053454A1 Compositions incorporating (-)-hydroxycitric acid, chromium, and gymnemic acid, and related methods for promoting healthy body weight and improving related health factors
07/03/2003WO2003053442A1 Tempamine compositions and methods of use
07/03/2003WO2003053407A1 Liposomal delivery of vitamin e based compounds
07/03/2003WO2003053347A2 Galliumcomplexes of 3-hydroxy-4-pyrones to treat mycobacterial infections
07/03/2003WO2003053169A1 Soft drink replacer
07/03/2003WO2003053165A1 Matrix-forming composition containing pectin
07/03/2003WO2003053146A1 Composition and method for improving sexual desire and overall sexual vitality
07/03/2003US20030125317 Vitronectin receptor antagonists
07/03/2003US20030125301 Blocking postprandial glycemic response by feeding a dual induced viscosity fiber system of soluble fiber, water-insoluble, acid- soluble metal or metal compound (calcium carbonate) and a hydrolyzed starch; dietetics;
07/03/2003US20030125265 Administering to a cancer paient a compound (emodin, genistein) having anti-estrogen receptor activity and tyrosine kinase inhibitor activity to prevent esterogen receptor positive cancer cells
07/03/2003US20030125252 Administering to a vertebrate an effective osteogenesis stimulating amount of an RAR (retinoic acid receptor) antagonist to treat both metabolic or non-metabolic diseases; RAR antisense oligonucleotide
07/03/2003US20030124503 Sodium chloride, potassium chloride, glucose, insulin, calcium chloride, lidocaine; pyruvic acid or salt thereof; myocardial ischemia; protects in period of cardiac arrest
07/03/2003US20030124202 Formulations and methods for reducing skin irritation
07/03/2003US20030124201 Administering isotopically pure heavy water, carbonate or phosphate either containing deuterium and no hydrogen or hydrogen and no deuterium
07/03/2003US20030124181 Lipid carrier compositions with enhanced blood stability
07/03/2003US20030124111 Antimicrobial agent
07/03/2003US20030124093 Method for treating kidney disorders
07/03/2003US20030124087 Prevents an adhesion between tissues at an operated legion and have various shapes, comprising sodium carboxymethyl cellulose and gellan gum
07/03/2003CA2469047A1 Tempamine compositions and methods of use
07/03/2003CA2468083A1 Use of heterocyclic carboxamides to treat anemia
07/03/2003CA2463427A1 Compositions incorporating (-)-hydroxycitric acid, chromium, and gymnemic acid, and related methods for promoting healthy body weight and improving related health factors
07/02/2003EP1323436A1 Anti-adhesion barrier comprising carboxymethylcellulose and gellan gum
07/02/2003EP1323433A1 Compositions for preventing urinary calculus
07/02/2003EP1323423A1 Combined preparations comprising anthracycline derivatives
07/02/2003EP1322274A1 Therapeutic topical solution for skin and associated methods of use
07/02/2003EP1322186A1 Medicinal beverage containing molecular oxygen
07/02/2003EP1322175A2 Food supplement
07/02/2003CN1427846A Uridine derivatives as antibiotics
07/02/2003CN1427716A Carbohydrate medical solution and sulphite stabilisator in multiple compartment container and use thereof
07/02/2003CN1426786A Ointment made of Chinese medicinal herbs for treating bedsore difficult to cure
07/01/2003US6586608 Emulsification of calcium carbonate or acetate in fatty acids or esters, by mixing and heating, then cooling and recovering the remaining fluid of the mixtures; mineralization; dosage
07/01/2003US6586476 Methods for the treatment of nephro-disorders using aminothiol compounds
07/01/2003US6586428 Combined preparations comprising morpholine anthracyclines and anticancer agent
07/01/2003US6585997 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
07/01/2003US6585890 Process for producing sterile water for injection from potable water
06/2003
06/26/2003WO2003052091A1 Growth factor modified protein matrices for tissue engineering
06/26/2003WO2003051979A2 Compositions and methods for high sorption of skin materials and delivery of sulfur
06/26/2003WO2003051384A1 Method for treating cervical cancer
06/26/2003WO2003051371A1 Composition of estrogen and other hormones with ascorbate, lysine, proline and other substances
06/26/2003WO2003051294A2 Mitocidal compositions and methods
06/26/2003WO2003051281A2 Composition and method to treat viral bacterial and parasitic infections and infestations
06/26/2003WO2002090515A3 Compositions and methods for reducing cytotoxicity and inhibiting angiogenesis
06/26/2003WO2002080945A3 Methods for treating the inflammatory component of a brain disorder
06/26/2003US20030119913 Method for increasing serotonin levels in a person by administration of a composition incorporating (-)-hydroxycitric acid, and related compositions thereof
06/26/2003US20030119895 Anticancer agents
06/26/2003US20030119804 Otic microbial combination for treatment of animals with ruptured tympanic membrane
06/26/2003US20030119755 Methods for alleviating mucositis
06/26/2003US20030119735 Delivery system
06/26/2003US20030118669 Novel substituted benzimidazole dosage forms and method of using same
06/26/2003US20030118668 Aquamarine salts having a chloride to sodium ratio of 1.4:1, iodized sodium chloride and sodium bicarbonate; topical treatment of tinea cruris, persistent diabetic lesions, perianal rash, fungus and yeast infections
06/26/2003US20030118667 Composition comprising camptothecin or a comptothecin derivative and a platin derivative for the treatment of cancer
06/26/2003US20030118666 Injectable solution containing a shark-derived chondroitin sulfate iron colloid
06/26/2003US20030118657 Treatment of disease states characterized by excessive or inappropriate angiogenesis
06/26/2003US20030118629 Water-in-oil emulsions with anionic groups, compositions, and methods
06/26/2003US20030118623 Composition based on etyl ester of linoleic acid and triethyl ester of citric acid for topical use in the treatment of seborrhea and acne
06/26/2003US20030118581 Adsorbent for oral administration
06/26/2003US20030118526 Mixture containing sunscreen agent; storage stability
06/26/2003US20030118517 Topical oral dosage forms containing bismuth compounds
06/26/2003CA2746308A1 Method for treating human papilloma virus
06/26/2003CA2471260A1 Compositions and methods for high sorption of skin materials and delivery of sulfur
06/26/2003CA2470582A1 Mitocidal compositions and methods
06/26/2003CA2470419A1 Growth factor modified protein matrices for tissue engineering
06/25/2003EP1321434A1 Method and apparatus for preparing aqueous dispersion of ultra-fine active carbon particles
06/25/2003EP1156777B1 Oral composition for inhibiting oral malodor
06/25/2003EP1019036B1 Use of d-methionine to reduce the toxicity of ototoxic drugs and noise
06/25/2003EP0980205B1 Use of a combination of tall-104 cells with adriamycin or cisplatin in the therapy of malignancies
06/25/2003EP0912442B8 Use of silica as agent for controlling the degradation of bicarbonate, resulting mixture and its application
06/25/2003EP0756485B1 Veterinary formulations containing disodium octaborate tetrahydrate
06/25/2003CN1426302A Brain, spinal and nerve injure treatment
06/25/2003CN1426296A Hemostat agent, method and carrier for applying blood clotting agent
06/25/2003CN1425446A Pill for activating collateral flow and removing spur
06/25/2003CN1425445A Gubenhuiyuan traditional Chinese medicine composition and its method for producing oral liquid
1 ... 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 ... 563